GleamWall
中文EN

OBIO Orchestra BioMed Holdings, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1814114 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1,007.4%
TTM net income YoY24.2%
TTM EPS YoY58.3%
Revenue 3-yr CAGR105.4%
Net income 3-yr CAGR—

Margins

Gross margin99.6%
Operating margin-195.4%
Net margin-182.5%
FCF margin-205.7%
EBITDA margin-194.2%

Returns

ROE-221.1%
ROA-53.6%
ROIC (approx.)—
Asset turnover0.29x

Leverage & solvency

Liabilities / assets82.6%
Debt / equity0.00x
Current ratio7.25x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.11x
Accruals ratio6.0%
Payout ratio—
Capex / revenue2.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$33.48M$2.64M
Cost of revenue$190,000$204,000
Gross profit$33.29M$2.43M
R&D expense$58.19M$42.80M
SG&A expense$26.91M$23.93M
Operating income-$51.81M-$64.30M
Interest expense—$297,000
Income tax$0—
Net income-$52.70M-$61.02M
EBITDA-$51.48M-$63.99M
EPS (basic)-1.11-1.66
EPS (diluted)-1.11-1.66
Weighted avg. shares (diluted)47.75M36.82M
Balance sheet
Cash & equivalents$34.69M$22.26M
Short-term investments$71.82M$44.55M
Receivables$95,000$92,000
Inventory$310,000$173,000
Current assets$107.91M$69.17M
PP&E, net$1.72M$1.38M
Total assets$114.86M$76.17M
Current liabilities$16.74M$16.21M
Long-term debt$15.00M$15.00M
Total debt$15.00M$15.00M
Total liabilities$51.48M$43.22M
Shareholders' equity$53.57M$32.96M
Net debt-$19.69M-$7.26M
Shares outstanding57.03M38.19M
Cash flow statement
Operating cash flow-$48.96M-$50.56M
Capital expenditure$489,000$289,000
Free cash flow-$49.45M-$50.85M
Investing cash flow-$26.94M$13.09M
Financing cash flow$88.33M$29.17M
Depreciation & amortization$327,000$308,000
Stock-based compensation$11.98M$10.62M

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.